Odyssey Therapeutics ODTX
NASDAQ ODTX
$19.36 +0.22 (+1.15%)
At close: Nov 16, 2026 · 4:00 PM EST

Odyssey Therapeutics (ODTX) Research & Development (2023 - 2026)

Updated

Odyssey Therapeutics (ODTX) posted Research & Development of $42.12 million for Q3 2026, up 60.0% from $26.33 million a year earlier and up 16.3% from the prior quarter.

Analysis

Odyssey Therapeutics (ODTX) Research & Development (2023 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Research & Development at Odyssey Therapeutics was $141.96 million, up 11.9% year-over-year; for FY2025, it came in at $126.62 million, up 12.5% from FY2024.

  • Annual Research & Development has increased for three consecutive years, with a three-year compound annual growth rate of 7.6% (FY2022 to FY2025).
  • In prior years, Odyssey Therapeutics' Research & Development was $112.58 million in FY2024 (+0.3%), $112.28 million in FY2023 (+10.3%) and $101.76 million in FY2022.
  • The Q3 2026 figure stands as the highest quarterly Research & Development in data going back to Q4 2023.
  • On a year-over-year basis, Research & Development increased in three of the last five quarters, with growth averaging 16.9%.
  • According to Business Quant data, Research & Development for the three prior quarters was $36.23 million (Q2 2026), $32.32 million (Q1 2026) and $31.29 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 4.25 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 4.65 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 2.57 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 4.54 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 3.89 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 2.11 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 1.61 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 3.02 Bn
10 Odyssey Therapeutics 929.15 Mn -64.53 Mn - 42.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 42.12 Mn
Jun 30, 2026 36.23 Mn
Mar 31, 2026 32.32 Mn
Dec 31, 2025 31.29 Mn
Sep 30, 2025 26.33 Mn
Jun 30, 2025 30.23 Mn
Mar 31, 2025 38.77 Mn
Dec 31, 2024 31.48 Mn
Dec 31, 2023 25.80 Mn
API Access

Odyssey Therapeutics Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=ODTX&period=max&api_key=YOUR_API_KEY